Clinical Trial Update: Prophylactic Urethral Stenting With Memokath After Prostate Implantation for Prostate Adenocarcinoma [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating prophylactic Memokath urethral stents after prostate brachytherapy in men with prostate cancer; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Outlet Obstruction
• Prostate Cancer

Drugs mentioned

• Memokath urethral stent (memokath urethral stent)

Snippet

Sponsor: The Cleveland Clinic | Conditions: Prostate Cancer, Post-Brachytherapy Bladder Outlet Obstruction | Phase 1, Phase 2 | Status: COMPLETED